HIMS & HERS HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.5 USD | +1.87% |
|
+5.04% | +40.45% |
| Apr. 26 | Seaport Global Starts Hims & Hers Health With Buy Rating | MT |
| Apr. 16 | Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17 | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 249 | 367.3 | 1,336 | 1,332 | 1,887 | 2,683 | - | - |
| Enterprise Value (EV) 1 | 249 | 339.9 | 1,263 | 1,284 | 1,789 | 2,465 | 2,301 | 2,683 |
| P/E ratio | -10.5 x | -63.5 x | -11.3 x | -20 x | -80.9 x | 164 x | 55.8 x | 36.6 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 3.02 x | 2.47 x | 4.91 x | 2.53 x | 2.16 x | 2.25 x | 1.83 x | 1.48 x |
| EV / Revenue | 3.02 x | 2.29 x | 4.65 x | 2.44 x | 2.05 x | 2.07 x | 1.57 x | 1.48 x |
| EV / EBITDA | - | -41.9 x | -42 x | -81.4 x | 36.1 x | 21.8 x | 14.2 x | 11.4 x |
| EV / FCF | - | -80.6 x | -35.8 x | -43.9 x | 31.8 x | 27.5 x | 14 x | 11 x |
| FCF Yield | - | -1.24% | -2.79% | -2.28% | 3.14% | 3.64% | 7.15% | 9.06% |
| Price to Book | - | -11.6 x | 3.66 x | 4.21 x | 5.42 x | 6.06 x | 4.64 x | - |
| Nbr of stocks (in thousands) | 25,156 | 25,156 | 203,913 | 207,739 | 211,994 | 214,649 | - | - |
| Reference price 2 | 9.900 | 14.60 | 6.550 | 6.410 | 8.900 | 12.50 | 12.50 | 12.50 |
| Announcement Date | 10/23/20 | 3/18/21 | 2/22/22 | 2/27/23 | 2/26/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 82.56 | 148.8 | 271.9 | 526.9 | 872 | 1,193 | 1,466 | 1,812 |
| EBITDA 1 | - | -8.114 | -30.08 | -15.78 | 49.52 | 113 | 161.6 | 236.2 |
| EBIT 1 | - | -15.14 | -115 | -68.7 | -29.45 | 22.78 | 62.43 | 112.8 |
| Operating Margin | - | -10.18% | -42.31% | -13.04% | -3.38% | 1.91% | 4.26% | 6.23% |
| Earnings before Tax (EBT) 1 | - | -17.99 | -110.8 | -65.71 | -21.57 | 31.15 | 71.86 | 122 |
| Net income 1 | - | -18.11 | -107.7 | -65.68 | -23.55 | 24.24 | 52.83 | 80.99 |
| Net margin | - | -12.18% | -39.6% | -12.46% | -2.7% | 2.03% | 3.6% | 4.47% |
| EPS 2 | -0.9400 | -0.2300 | -0.5800 | -0.3200 | -0.1100 | 0.0761 | 0.2241 | 0.3417 |
| Free Cash Flow 1 | - | -4.216 | -35.24 | -29.24 | 56.26 | 89.77 | 164.6 | 243 |
| FCF margin | - | -2.83% | -12.96% | -5.55% | 6.45% | 7.53% | 11.22% | 13.41% |
| FCF Conversion (EBITDA) | - | - | - | - | 113.63% | 79.45% | 101.87% | 102.87% |
| FCF Conversion (Net income) | - | - | - | - | - | 370.4% | 311.57% | 300.03% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 10/23/20 | 3/18/21 | 2/22/22 | 2/27/23 | 2/26/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 74.17 | 84.7 | 101.3 | 113.6 | 144.8 | 167.2 | 190.8 | 207.9 | 226.7 | 246.6 | 268.6 | 285.5 | 304.4 | 322.3 | 334.7 |
| EBITDA 1 | -9.788 | -7.059 | -6.061 | -7.541 | -6.096 | 3.919 | 6.06 | 10.64 | 12.25 | 20.57 | 23.66 | 25.35 | 27.38 | 31.48 | 36.84 |
| EBIT 1 | -27.66 | -21.56 | -16.92 | -20.19 | -19.98 | -11.6 | -11.26 | -9.236 | -8.554 | -0.4 | 3.929 | 4.007 | 4.318 | 9.658 | 14.23 |
| Operating Margin | -37.29% | -25.46% | -16.7% | -17.78% | -13.8% | -6.94% | -5.9% | -4.44% | -3.77% | -0.16% | 1.46% | 1.4% | 1.42% | 3% | 4.25% |
| Earnings before Tax (EBT) 1 | -19.11 | -31.25 | -16.16 | -19.67 | -18.86 | -11.03 | -9.681 | -7.17 | -6.916 | 2.196 | 5.905 | 6.002 | 6.273 | 11.81 | 15.52 |
| Net income 1 | -15.94 | -31.16 | -16.25 | -19.68 | -18.84 | -10.91 | -10.07 | -7.157 | -7.567 | 1.245 | 4.702 | 4.835 | 5.031 | 9.603 | 11.16 |
| Net margin | -21.49% | -36.79% | -16.04% | -17.33% | -13.01% | -6.52% | -5.28% | -3.44% | -3.34% | 0.5% | 1.75% | 1.69% | 1.65% | 2.98% | 3.33% |
| EPS 2 | -0.0800 | -0.1500 | -0.0800 | -0.1000 | -0.0900 | -0.0500 | -0.0500 | -0.0300 | -0.0400 | 0.0100 | 0.0102 | 0.0138 | 0.0174 | 0.0305 | 0.0510 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/10/21 | 2/22/22 | 5/9/22 | 8/8/22 | 11/7/22 | 2/27/23 | 5/8/23 | 8/7/23 | 11/6/23 | 2/26/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 27.3 | 72.6 | 47.6 | 97.5 | 218 | 382 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -4.22 | -35.2 | -29.2 | 56.3 | 89.8 | 165 | 243 |
| ROE (net income / shareholders' equity) | - | -24.2% | -32.2% | -20.3% | -7.18% | 7.43% | 22.6% | 35.5% |
| ROA (Net income/ Total Assets) | - | - | - | -16.7% | -5.83% | 6.04% | 9.89% | - |
| Assets 1 | - | - | - | 393.5 | 403.8 | 401.2 | 533.9 | - |
| Book Value Per Share 2 | - | -1.260 | 1.790 | 1.520 | 1.640 | 2.060 | 2.690 | - |
| Cash Flow per Share 2 | - | -0.0300 | -0.1800 | -0.1300 | 0.3500 | 0.5700 | 0.7500 | - |
| Capex 1 | - | 1.74 | 0.83 | 2.71 | 17.2 | 23.5 | 19.2 | 26.7 |
| Capex / Sales | - | 1.17% | 0.31% | 0.52% | 1.97% | 1.97% | 1.31% | 1.47% |
| Announcement Date | 10/23/20 | 3/18/21 | 2/22/22 | 2/27/23 | 2/26/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
12.5
USD
Average target price
14.94
USD
Spread / Average Target
+19.54%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +40.45% | 2.68B | |
| +22.83% | 527M | |
| +42.77% | 467M | |
| -64.56% | 156M | |
| -31.65% | 85.12M |
- Stock Market
- Equities
- HIMS Stock
- Financials Hims & Hers Health, Inc.
